Polarean Imaging plc - First patient in Phase III FDA Clinical Trial

POLX

Wed, 29 Aug 2018, 08:00am BST

We speak with Richard Hullihen, CEO of Polarean, following the successful enrolment of the first patient into the Phase III clinical trial which aims to demonstrate non-inferiority of the Company's drug/device combination

Richard Hullihen

CEO

POLX

5b801654f611656781ee4eaf

00:00

00:00

00:00

speed

0.5X

1.0X

1.5X

2.0X

SHOW MORE
FROM THIS COMPANY

Polarean Imaging plc - First patient in Phase III FDA Clinical Trial

POLX

Wed, 29 Aug 2018, 08:00am BST

We speak with Richard Hullihen, CEO of Polarean, following the successful enrolment of the first patient into the Phase III clinical trial which aims to demonstrate non-inferiority of the Company's drug/device combination

Richard Hullihen

CEO

POLX

POWERED BY

You can embed this event or share the direct link

DIRECT LINK

URL

https://www.brrmedia.co.uk/broadcasts-embed/5b801654f611656781ee4eaf/?event&popup=true

EMBED IN YOUR WEBSITE

HTML

<div class="BRRPlayer_wrapper" style="width:80%;height:100%;margin:0 auto;background:#CCC"><div class="BRRPlayer_h_iframe" style="position:relative;"><img class="BRRPlayer_ratio" style="display:block;width:100%;height:auto;" src="https://www.brrmedia.co.uk/wp-content/plugins/brr_uk/images/placeholder_image_for_iframes.png"/><iframe style="position:absolute;top:0;left:0;width:100%; height:100%;" src="https://www.brrmedia.co.uk/broadcasts-embed/5b801654f611656781ee4eaf/?event&popup=true?embedded=true" frameborder="0" allowfullscreen></iframe></div></div>